prostate cancer

https://grandroundsinurology.com/episwitch-prostate-screening-pse-blood-test/ Garrett D. Pohlman, MD, discusses his experience with the EpiSwitch® Prostate Screening (PSE) Blood Test in his practice. This presentation was supported by Oxford BioDynamics. He begins with a brief overview of...

The Gabe Canales story and how it can help you and your sons and grandsons. Prostate cancer typically is diagnosed in men in their 60s. It’s considered a disease of aging, an old man’s disease. But Gabe Canales, a marketing & communications expert from Houston Texas, was diagnosed at age 35. It...

In this engaging episode, Dr. Geo sits down with Dr. Behfar Ehdaie, a renowned urologic surgeon from Memorial Sloan Kettering Cancer Center, for an insightful discussion on prostate cancer treatment. The focus is on High-Intensity Focused Ultrasound (HIFU) as a focal therapy for prostate cancer...

A recording of the lecture I gave at Monash University in March 2024 on the topic of men's intimate health. Check out my podcast, The Penis Project, for all things men’s intimate health. I chat to industry-leading experts, clinicians, researchers and patients with lived experience...

In summary, the paper by Melao et al. supports the concept that a low serum T prior to RP may be an adverse prognostic factor and low T may interfere with erectile recovery, but much more work needs to be done. Is there a relationship between testosterone and androgen receptor with...

Did you know androgen deprivation therapy (ADT) lowers testosterone levels, which then causes prostate cancer cells to die? On July 10th, PHEN held a Managing Survivorship Webinar where Dr. Alicia Morgans, Medical Director of the Survivorship Program at the Dana-Farber Cancer Institute, outlined...

Dr. Morgentaler back in action! Listen closely, loved this one! Pros/Cons oral TU (51:24-57:12) * one of the things that the orals have transformed is the concept that you have to have a continually high level of testosterone to get the benefits and clearly that's not true and the...

In this episode of the Dr. Geo Podcast, Dr. Geo sits down with Dr. Xiaosong Meng from UT Southwestern Medical Center to discuss TULSA (Transurethral Ultrasound Ablation), an advanced focal treatment for prostate cancer. They explore how TULSA works, its benefits, and how it compares to other...

In this episode, Dr. Geo Espinosa sits down with Dr. Arvin George, a renowned urologic surgeon from Johns Hopkins specializing in prostate cancer, to delve into the world of focal therapy. They discuss what focal therapy is, its side effects, and various energy types used in treating prostate...

A balance among infections, antimicrobial stewardship and prostate cancer detection: TP vs TRUS prostate biopsy Prostate biopsies are the key step to diagnose prostate cancer and one of the most performed procedures in urology. The biopsy can be performed either the trans-perineal (TP) way or...

Chapters: 0:34 What is testosterone replacement therapy (TRT)? 2:29 What is the dosing? 2:50 Explain adding testosterone when you are on ADT? 4:43 What is a normal testosterone level and one for someone on ADT? 7:10 How does quality of life and testosterone level relate? 7:55 Does...

Great webinar! Our aim is to assess the effects of testosterone replacement therapy (TRT) on male health indicators in hypogonadal men, and the impact on sexual quality of life and prostate cancer risk. Testosterone prescriptions have nearly tripled in recent years; however, it is clear...

Great webinar! Nelson's house is where it's at! 3:20-18:38 * Safety of TTh in men with treated or low-grade in-situ prostate cancer is unknown * Will never have a study large enough to know true impact of T on prostate cancer development/progression

In the video, Dr. Marshalls, a medical oncologist with 30 years of experience in prostate cancer, discusses various blood tests used for prostate cancer screening. He explains the limitations of PSA (Prostate-Specific Antigen) tests, which can indicate issues with the prostate gland but are not...

https://ascopost.com/videos/2024-asco-annual-meeting/alicia-morgans-and-samuel-denmeade-on-prostate-cancer-results-from-the-transformer-trial/

Another great interview from Dr. Bernie! * debunk the long-standing myth that testosterone fuels prostate cancer In this episode, Dr. Geo interviews Dr. Helen Bernie from Indiana University about Testosterone Replacement Therapy (TRT) post-prostate cancer diagnosis and treatment. They...

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results.

Join Dr. Geo as he delves into the genetics behind prostate cancer with Dr. Eric Klein, a renowned expert in the field. This episode covers the role of genetic predispositions, the science behind liquid biopsies, and their application in cancer detection, particularly prostate cancer. Dr. Klein...

Men have many challenges to deal with when battling prostate cancer, including managing the side effects of their treatment. One common issue men face after a radical prostatectomy is erectile dysfunction. As June is Men's Health Month, we are fortunate to have men's health expert Dr. Helen...

ABSTRACT Men with hypogonadism have reduced risk of prostate cancer mortality; whether testosterone treatment increases the risk of prostate safety events in men with hypogonadism remains controversial. Several studies including four larger randomized trials — the Testosterone Trials...

Lesson 20 https://auau.auanet.org/content/update-series-2024-audio-playlist?destination=node/38867/course-outline#group-tabs-node-course-default1

In this episode of the Dr. Geo Podcast, Dr. Geo sits down with Dr. Daniel Margolis, a professor of radiology and the director of prostate MRI at Weill Cornell Medicine, to discuss the importance of MRI in prostate cancer screening. They delve into the essentials of MRI technology, the expertise...

The EAU Guidelines Office will provide a state-of-the-art update on male hypogonadism and testosterone replacement therapy. This recording will be of great educational value for urologists as internationally-known experts will focus on the controversial and challenging areas of this rapidly...

Chapters Timeline: 4:48 Physical activity and exercise are important to make you feel better plus mental health booster 5:31 What comes to mind from the Genetics lecture? 9:24 How does liquid biopsies relate to early screening? 14:29 15-20 years ago total body CT scans not finding...

0:22 What is the difference between a "genetic" and a "genomic" test? 1:12 How important is genetic or genomic testing to the average prostate cancer patient? 3:31 Do 5% of people have a BRCA mutation? 3:42 Should all prostate cancer patients test to see if they have a BRCA mutation? 5:09...

"We've been doing a lot of work at Johns Hopkins using high-dose testosterone therapies to treat patients with metastatic prostate cancer," says Mark C. Markowski, MD, PhD. https://www.urologytimes.com/view/bipolar-androgen-therapy-in-prostate-cancer-current-evidence-and-next-steps In this...

Background and purpose To determine the rate and time of testosterone (T) recovery in patients (pts) with localised prostate cancer treated with radiotherapy plus 0-, 6-, 18- or 36-month of androgen deprivation therapy (ADT).Materials and methods In 1230 pts with prostate cancer randomised into...

https://pcri.org/2024-midyear-update

Dr. Michael Kipper, MD is one of the nation’s foremost experts in PET/CT imaging technology for the diagnosis of cancer and brain disorders. He is the author of several medical textbooks and numerous professional journal articles on imaging techniques for the evaluation of cancer and other...

10 Years of MRI-Targeted Biopsy: What We Have Learned, and What We Have Yet to Learn by Samir S. Taneja, MD, The James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology, Professor of Urology, Radiology, and Biomedical Engineering, GU Program Leader, Perlmutter Cancer Center...

I was recently honored to be a guest speaker among the innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February. Today, I am delighted to have one of the Society of...